What smart money is saying about Supernus Pharmaceuticals
SUPN
No fund has written a full thesis on Supernus Pharmaceuticals in our archive, but 1 fund letter reports a position in it, most recently Third Avenue Small-Cap Value Fund in June 2026.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Supernus Pharmaceuticals on record in the archive was reported in Q2 2026, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position
- June 2026
“Companies detracting from Fund performance this quarter included offshore energy services company Tidewater, fertilizer producer LSB Industries, pharmaceuticals company Supernus, oil and gas producer SandRidge Energy, and government consulting company Maximus.”
Supernus Pharmaceuticals
Read the letters behind these Supernus Pharmaceuticals positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger